PRIMARY STUDY
Cannabis-Containing Cream for CKD-Associated Pruritus: A Double-Blind, Placebo Controlled Trial
Key Findings: In a double-blind randomized study, a cannabis cream significantly reduced chronic kidney disease-associated pruritus in hemodialysis patients compared to a placebo, although statistical significance was not maintained for secondary skin quality outcomes.
Type of Study: Double Blind Clinical Trial
Study Sample Size: 60
Study Result: Positive
Research Location(s): Thailand
Year of Pub: 2024
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source: Hemp derived
Chemotype: Chemotype III
Route of Administration: , Topical
Citation: Anumas S, et al. Cannabis-Containing Cream for CKD-Associated Pruritus: A Double-Blind, Placebo Controlled Trial. Kidney Med. 2024; 6:100894. doi: 10.1016/j.xkme.2024.100894
Authors: Anumas S, Kuropakornpong P, Chakkavittumrong P, Tasanarong A, Pattharanitima P
